nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acrokeratosis Paraneoplastica (Bazex Syndrome) Presenting in a Patient with Metastatic Breast Carcinoma: Possible Etiologic Role of Zinc
|
Taher, Muba |
|
2007 |
11 |
2 |
p. 78-83 |
artikel |
2 |
Challenges and Solutions in Selecting Systemic Antipsoriatic Agents
|
Tan, Jerry K.L. |
|
2007 |
11 |
2 |
p. S48-S53 |
artikel |
3 |
Correction
|
|
|
2007 |
11 |
2 |
p. 88-88 |
artikel |
4 |
Efalizumab for the Treatment of Psoriatic Arthritis
|
Papp, Kim A. |
|
2007 |
11 |
2 |
p. 57-66 |
artikel |
5 |
Efficacy of Etanercept in the Management of Plaque Psoriasis and Psoriatic Arthritis
|
Poulin, Yves |
|
2007 |
11 |
2 |
p. S14-S22 |
artikel |
6 |
Etanercept: A Novel Tumor Necrosis Factor Antagonist for the Treatment of Psoriatic Disease
|
Papp, Kim A. |
|
2007 |
11 |
2 |
p. S1-S2 |
artikel |
7 |
Incidence of Nonmelanoma Skin Cancer in New Brunswick, Canada, 1992 to 2001
|
Hayes, Robert C. |
|
2007 |
11 |
2 |
p. 45-52 |
artikel |
8 |
Invasive Trichophyton Rubrum Infection Occurring with Infliximab and Long-Term Prednisone Treatment
|
Lowther, Abigail L. |
|
2007 |
11 |
2 |
p. 84-88 |
artikel |
9 |
Long-Term Safety of Etanercept
|
Langley, Richard G. |
|
2007 |
11 |
2 |
p. S23-S36 |
artikel |
10 |
Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology
|
Papp, Kim A. |
|
2007 |
11 |
2 |
p. S3-S13 |
artikel |
11 |
No Show: Incidence of Nonattendance at a Dermatology Practice in a Single Universal Payer Model
|
Pehr, Kevin |
|
2007 |
11 |
2 |
p. 53-56 |
artikel |
12 |
Practical Considerations for the Initiation and Maintenance of Etanercept in the Treatment of Psoriasis
|
Guenther, Lyn |
|
2007 |
11 |
2 |
p. S37-S47 |
artikel |
13 |
Treatment of Focal Hyperhidrosis
|
Murray, Christian A. |
|
2007 |
11 |
2 |
p. 67-77 |
artikel |